Role of microRNAs in regulation of doxorubicin and paclitaxel responses in lung tumor cells

[1]  Zhiyong Zhang,et al.  Hsa_circ_0092887 targeting miR‐490‐5p/UBE2T promotes paclitaxel resistance in non‐small cell lung cancer , 2022, Journal of clinical laboratory analysis.

[2]  M. Abbaszadegan,et al.  PI3K/AKT signaling pathway as a critical regulator of Cisplatin response in tumor cells , 2022, Oncology research.

[3]  Ahmed S. Doghish,et al.  A study of miRNAs as cornerstone in lung cancer pathogenesis and therapeutic resistance: A focus on signaling pathways interplay. , 2022, Pathology, research and practice.

[4]  Haitao Ma,et al.  Exosomal circDNER enhances paclitaxel resistance and tumorigenicity of lung cancer via targeting miR‐139‐5p/ITGB8 , 2022, Thoracic cancer.

[5]  Han Wang,et al.  Circular RNA hsa_circ_0011298 enhances Taxol resistance of non‐small cell lung cancer by regulating miR‐486‐3p/CRABP2 axis , 2022, Journal of clinical laboratory analysis.

[6]  Y. Liu,et al.  Circ_0011292 knockdown mitigates progression and drug resistance in PTX‐resistant non‐small‐cell lung cancer cells by regulating miR‐433‐3p/CHEK1 axis , 2022, Thoracic cancer.

[7]  J. Guan,et al.  miR-1247-3p targets STAT5A to inhibit lung adenocarcinoma cell migration and chemotherapy resistance , 2022, Journal of Cancer.

[8]  M. Moghbeli,et al.  MicroRNAs as the critical regulators of tyrosine kinase inhibitors resistance in lung tumor cells , 2022, Cell Communication and Signaling.

[9]  M. Moghbeli,et al.  Long non-coding RNAs as the critical regulators of epithelial mesenchymal transition in colorectal tumor cells: an overview , 2022, Cancer Cell International.

[10]  M. Abbaszadegan,et al.  MicroRNA-217: a therapeutic and diagnostic tumor marker , 2021, Expert review of molecular diagnostics.

[11]  Hui Zhang,et al.  Downregulation of LINC01296 suppresses non-small-cell lung cancer via targeting miR-143-3p/ATG2B. , 2021, Acta biochimica et biophysica Sinica.

[12]  M. Moghbeli,et al.  Long non-coding RNAs as the critical regulators of doxorubicin resistance in tumor cells , 2021, Cellular & molecular biology letters.

[13]  Y. Liu,et al.  Circ_0001821 knockdown suppresses growth, metastasis, and TAX resistance of non‐small‐cell lung cancer cells by regulating the miR‐526b‐5p/GRK5 axis , 2021, Pharmacology research & perspectives.

[14]  Hucheng Chen,et al.  MiR-194-5p enhances the sensitivity of nonsmall-cell lung cancer to doxorubicin through targeted inhibition of hypoxia-inducible factor-1 , 2021, World Journal of Surgical Oncology.

[15]  M. Moghbeli,et al.  MicroRNAs as the critical regulators of cisplatin resistance in gastric tumor cells , 2021, Genes and environment : the official journal of the Japanese Environmental Mutagen Society.

[16]  Xiongwen Zhang,et al.  Autophagy inhibition and microRNA-199a-5p upregulation in paclitaxel-resistant A549/T lung cancer cells , 2021, Oncology reports.

[17]  M. Moghbeli.  Molecular interactions of miR-338 during tumor progression and metastasis , 2021, Cellular & molecular biology letters.

[18]  Jia-Yu Pan,et al.  Overexpression of hsa_circ_0002874 promotes resistance of non-small cell lung cancer to paclitaxel by modulating miR-1273f/MDM2/p53 pathway , 2021, Aging.

[19]  M. Elshafey,et al.  MicroRNA-567 inhibits cell proliferation and induces cell apoptosis in A549 NSCLC cells by regulating cyclin-dependent kinase 8 , 2021, Saudi journal of biological sciences.

[20]  Haocai Chang,et al.  Targeting autophagy to overcome drug resistance: further developments , 2020, Journal of Hematology & Oncology.

[21]  Yiling Feng,et al.  A novel circular RNA, hsa_circ_0030998 suppresses lung cancer tumorigenesis and Taxol resistance by sponging miR‐558 , 2020, Molecular oncology.

[22]  M. Mojarrad,et al.  Non coding RNAs as the critical factors in chemo resistance of bladder tumor cells , 2020, Diagnostic Pathology.

[23]  C. Lutz,et al.  miR-708-5p enhances erlotinib/paclitaxel efficacy and overcomes chemoresistance in lung cancer cells , 2020, Oncotarget.

[24]  I. Pavlinov,et al.  Beclin 1-ATG14L Protein-Protein Interaction Inhibitor Selectively Inhibits Autophagy through Disruption of VPS34 Complex I. , 2020, Journal of the American Chemical Society.

[25]  J. Gong,et al.  STAT5a induces endotoxin tolerance by alleviating pyroptosis in kupffer cells. , 2020, Molecular immunology.

[26]  Yunping Zhao,et al.  MicroRNA-34c-3p target inhibiting NOTCH1 suppresses chemosensitivity and metastasis of non-small cell lung cancer , 2020, The Journal of international medical research.

[27]  Shi-kun He,et al.  Autophagy and autophagy-related proteins in cancer , 2020, Molecular cancer.

[28]  M. Mojarrad,et al.  Long non-coding RNAs as the critical factors during tumor progressions among Iranian population: an overview , 2020, Cell & Bioscience.

[29]  W. Jin.  Role of JAK/STAT3 Signaling in the Regulation of Metastasis, the Transition of Cancer Stem Cells, and Chemoresistance of Cancer by Epithelial–Mesenchymal Transition , 2020, Cells.

[30]  Juze Yang,et al.  Long noncoding RNA LCAT1 functions as a ceRNA to regulate RAC1 function by sponging miR-4715-5p in lung cancer , 2019, Molecular Cancer.

[31]  Liang Liu,et al.  MicroRNA-421 confers paclitaxel resistance by binding to the KEAP1 3′UTR and predicts poor survival in non-small cell lung cancer , 2019, Cell Death & Disease.

[32]  X. Ao,et al.  MicroRNA-608 Promotes Apoptosis in Non-Small Cell Lung Cancer Cells Treated With Doxorubicin Through the Inhibition of TFAP4 , 2019, Front. Genet..

[33]  Sebastian Kadener,et al.  Past, present, and future of circRNAs , 2019, The EMBO journal.

[34]  Guosheng Xiong,et al.  Involvement of miR-4262 in paclitaxel resistance through the regulation of PTEN in non-small cell lung cancer , 2019, Open Biology.

[35]  M. Abbaszadegan,et al.  Role of MAML1 in targeted therapy against the esophageal cancer stem cells , 2019, Journal of Translational Medicine.

[36]  Hong Li,et al.  LncRNA MALAT1 Depressed Chemo-Sensitivity of NSCLC Cells through Directly Functioning on miR-197-3p/p120 Catenin Axis , 2019, Molecules and cells.

[37]  F. Speleman,et al.  Long noncoding RNA expression profiling in cancer: Challenges and opportunities , 2019, Genes, chromosomes & cancer.

[38]  J. Li,et al.  MicroRNA-302c represses epithelial-mesenchymal transition and metastasis by targeting transcription factor AP-4 in colorectal cancer. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[39]  Yiping Li,et al.  Elevated TFAP4 regulates lncRNA TRERNA1 to promote cell migration and invasion in gastric cancer. , 2018, Oncology reports.

[40]  Peng Cai,et al.  Knockdown of miR‑935 increases paclitaxel sensitivity via regulation of SOX7 in non‑small‑cell lung cancer. , 2018, Molecular medicine reports.

[41]  Alexander Pertsemlidis,et al.  miR-195 potentiates the efficacy of microtubule-targeting agents in non-small cell lung cancer. , 2018, Cancer letters.

[42]  Jun Yu Li,et al.  Transcription factor AP-4 promotes tumorigenic capability and activates the Wnt/β-catenin pathway in hepatocellular carcinoma , 2018, Theranostics.

[43]  L. Moyal,et al.  AN-7, a butyric acid prodrug, sensitizes cutaneous T-cell lymphoma cell lines to doxorubicin via inhibition of DNA double strand breaks repair , 2018, Investigational New Drugs.

[44]  Ying-hua Zhu,et al.  A miRNA-200c/cathepsin L feedback loop determines paclitaxel resistance in human lung cancer A549 cells in vitro through regulating epithelial–mesenchymal transition , 2017, Acta Pharmacologica Sinica.

[45]  H. Tallima,et al.  Arachidonic acid: Physiological roles and potential health benefits – A review , 2017, Journal of advanced research.

[46]  K. Rabe,et al.  Precision Diagnosis and Treatment for Advanced Non-Small-Cell Lung Cancer. , 2017, The New England journal of medicine.

[47]  M. Rauh,et al.  Nrf2-Keap1 pathway promotes cell proliferation and diminishes ferroptosis , 2017, Oncogenesis.

[48]  Arnab Ray Chaudhuri,et al.  The multifaceted roles of PARP1 in DNA repair and chromatin remodelling , 2017, Nature Reviews Molecular Cell Biology.

[49]  Y. Li,et al.  miR-30a-5p enhances paclitaxel sensitivity in non-small cell lung cancer through targeting BCL-2 expression , 2017, Journal of Molecular Medicine.

[50]  N. Leighl,et al.  Review of the use of pretest probability for molecular testing in non-small cell lung cancer and overview of new mutations that may affect clinical practice , 2017, Therapeutic advances in medical oncology.

[51]  Lei Liu,et al.  Curcumin increases the sensitivity of Paclitaxel-resistant NSCLC cells to Paclitaxel through microRNA-30c-mediated MTA1 reduction , 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[52]  Zhong-Qin Liang,et al.  Cathepsin L upregulation-induced EMT phenotype is associated with the acquisition of cisplatin or paclitaxel resistance in A549 cells , 2016, Acta Pharmacologica Sinica.

[53]  Dejia Li,et al.  The Novel miR-9600 Suppresses Tumor Progression and Promotes Paclitaxel Sensitivity in Non–small-cell Lung Cancer Through Altering STAT3 Expression , 2016, Molecular therapy. Nucleic acids.

[54]  Caihong Tan,et al.  Cathepsin L knockdown enhances curcumin-mediated inhibition of growth, migration, and invasion of glioma cells , 2016, Brain Research.

[55]  Renyuan Li,et al.  miR-223/FBW7 axis regulates doxorubicin sensitivity through epithelial mesenchymal transition in non-small cell lung cancer. , 2016, American journal of translational research.

[56]  E. Sikora,et al.  Curcumin-treated cancer cells show mitotic disturbances leading to growth arrest and induction of senescence phenotype. , 2016, The international journal of biochemistry & cell biology.

[57]  Y. Sang,et al.  Downregulation of miR-129-2 by promoter hypermethylation regulates breast cancer cell proliferation and apoptosis. , 2016, Oncology Report.

[58]  D. Sorriento,et al.  Dual role of GRK5 in cancer development and progression , 2016, Translational medicine @ UniSa.

[59]  Haiyang Xie,et al.  MicroRNA-452 promotes stem-like cells of hepatocellular carcinoma by inhibiting Sox7 involving Wnt/β-catenin signaling pathway , 2016, Oncotarget.

[60]  E. White.  Autophagy and p53. , 2016, Cold Spring Harbor perspectives in medicine.

[61]  Hua Shen,et al.  MicroRNA-137 inhibits tumor growth and sensitizes chemosensitivity to paclitaxel and cisplatin in lung cancer , 2016, Oncotarget.

[62]  Lixia Lv,et al.  Effect of miR-155 knockdown on the reversal of doxorubicin resistance in human lung cancer A549/dox cells. , 2016, Oncology letters.

[63]  A. G. de Herreros,et al.  F-box proteins: Keeping the epithelial-to-mesenchymal transition (EMT) in check. , 2016, Seminars in cancer biology.

[64]  X. Zhang,et al.  MiR-125a promotes paclitaxel sensitivity in cervical cancer through altering STAT3 expression , 2016, Oncogenesis.

[65]  M. Altmeyer,et al.  Readers of poly(ADP-ribose): designed to be fit for purpose , 2015, Nucleic acids research.

[66]  T. Zhu,et al.  Berberine Increases Doxorubicin Sensitivity by Suppressing STAT3 in Lung Cancer. , 2015, The American journal of Chinese medicine.

[67]  H. Um.  Bcl-2 family proteins as regulators of cancer cell invasion and metastasis: a review focusing on mitochondrial respiration and reactive oxygen species , 2015, Oncotarget.

[68]  Saurabh Ghosh,et al.  Sequence and expression variations in 23 genes involved in mitochondrial and non-mitochondrial apoptotic pathways and risk of oral leukoplakia and cancer. , 2015, Mitochondrion.

[69]  R. Mehrotra,et al.  Berberine and Curcumin Target Survivin and STAT3 in Gastric Cancer Cells and Synergize Actions of Standard Chemotherapeutic 5-Fluorouracil , 2015, Nutrition and cancer.

[70]  Haofeng Xi,et al.  Curcumin induces apoptosis in pancreatic cancer cells through the induction of forkhead box O1 and inhibition of the PI3K/Akt pathway. , 2015, Molecular medicine reports.

[71]  Hao Liu,et al.  MicroRNA-181a regulates epithelial-mesenchymal transition by targeting PTEN in drug-resistant lung adenocarcinoma cells. , 2015, International journal of oncology.

[72]  Li Yu,et al.  Downregulation of P-gp, Ras and p-ERK1/2 contributes to the arsenic trioxide-induced reduction in drug resistance towards doxorubicin in gastric cancer cell lines , 2015, Molecular medicine reports.

[73]  Jiezhong Chen,et al.  The critical roles of miR-21 in anti-cancer effects of curcumin. , 2015, Annals of translational medicine.

[74]  Z. Zong,et al.  MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs , 2015, Drug design, development and therapy.

[75]  Yan Dai,et al.  MicroRNA-299-3p promotes the sensibility of lung cancer to doxorubicin through directly targeting ABCE1. , 2015, International journal of clinical and experimental pathology.

[76]  David Gilligan,et al.  Treatment approaches for EGFR-inhibitor-resistant patients with non-small-cell lung cancer. , 2015, The Lancet. Oncology.

[77]  Guoxin Li,et al.  Novel Epigenetic CREB-miR-630 Signaling Axis Regulates Radiosensitivity in Colorectal Cancer , 2015, PloS one.

[78]  H. Cai,et al.  Curcumin inhibits the invasion of lung cancer cells by modulating the PKCα/Nox-2/ROS/ATF-2/MMP-9 signaling pathway. , 2015, Oncology reports.

[79]  M. Ibrahim,et al.  Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp , 2015, Cancer Cell International.

[80]  Peifeng Li,et al.  Phosphorylation of apoptosis repressor with caspase recruitment domain by protein kinase CK2 contributes to chemotherapy resistance by inhibiting doxorubicin induced apoptosis , 2015, Oncotarget.

[81]  T. Reinheckel,et al.  Stress-resistant Translation of Cathepsin L mRNA in Breast Cancer Progression* , 2015, The Journal of Biological Chemistry.

[82]  P. Račay,et al.  Gene expression abnormalities in histologically normal breast epithelium from patients with luminal type of breast cancer , 2015, Molecular Biology Reports.

[83]  D. Saluja,et al.  Curcumin modulates cellular AP-1, NF-kB, and HPV16 E6 proteins in oral cancer , 2015, Ecancermedicalscience.

[84]  Gang Chen,et al.  Downregulation of cathepsin L suppresses cancer invasion and migration by inhibiting transforming growth factor‑β‑mediated epithelial‑mesenchymal transition. , 2015, Oncology reports.

[85]  Zhiwei Wang,et al.  The functions of F-box proteins in regulating the epithelial to mesenchymal transition. , 2015, Current pharmaceutical design.

[86]  G. Sethi,et al.  Brassinin inhibits STAT3 signaling pathway through modulation of PIAS-3 and SOCS-3 expression and sensitizes human lung cancer xenograft in nude mice to paclitaxel , 2015, Oncotarget.

[87]  Xin-yang Wang,et al.  TNF-α induced epithelial mesenchymal transition increases stemness properties in renal cell carcinoma cells. , 2014, International journal of clinical and experimental medicine.

[88]  Hua Yu,et al.  Revisiting STAT3 signalling in cancer: new and unexpected biological functions , 2014, Nature Reviews Cancer.

[89]  M. Katoh.  Cardio-miRNAs and onco-miRNAs: circulating miRNA-based diagnostics for non-cancerous and cancerous diseases , 2014, Front. Cell Dev. Biol..

[90]  B. Jiang,et al.  Fas signaling promotes chemoresistance in gastrointestinal cancer by up-regulating P-glycoprotein , 2014, Oncotarget.

[91]  Jie Gu,et al.  MicroRNA-7 sensitizes non-small cell lung cancer cells to paclitaxel , 2014, Oncology letters.

[92]  Dong-Xu Liu,et al.  Knock-down of ABCE1 gene induces G1/S arrest in human oral cancer cells. , 2014, International journal of clinical and experimental pathology.

[93]  H. Xi,et al.  Decreased expression of Sox7 correlates with the upregulation of the Wnt/β-catenin signaling pathway and the poor survival of gastric cancer patients. , 2014, International journal of molecular medicine.

[94]  D. Fan,et al.  Multi-drug resistance in cancer chemotherapeutics: mechanisms and lab approaches. , 2014, Cancer letters.

[95]  A. Puisieux,et al.  Oncogenic roles of EMT-inducing transcription factors , 2014, Nature Cell Biology.

[96]  J. R. Vargas,et al.  Cell-Penetrating, Guanidinium-Rich Molecular Transporters for Overcoming Efflux-Mediated Multidrug Resistance , 2014, Molecular pharmaceutics.

[97]  Gopal Chakrabarti,et al.  miR-17-5p Downregulation Contributes to Paclitaxel Resistance of Lung Cancer Cells through Altering Beclin1 Expression , 2014, PloS one.

[98]  Guangchao Sui,et al.  SOX7: from a developmental regulator to an emerging tumor suppressor. , 2014, Histology and histopathology.

[99]  R. Beckmann,et al.  CHEK again: revisiting the development of CHK1 inhibitors for cancer therapy. , 2014, Pharmacology & therapeutics.

[100]  Bo-yuan Huang,et al.  Depleting ABCE1 expression induces apoptosis and inhibits the ability of proliferation and migration of human esophageal carcinoma cells. , 2014, International journal of clinical and experimental pathology.

[101]  D. Klionsky,et al.  The machinery of macroautophagy , 2013, Cell Research.

[102]  J. Dhanjal,et al.  Mechanistic insights into mode of action of novel natural cathepsin L inhibitors , 2013, BMC Genomics.

[103]  Thomas Kirchner,et al.  AP4 is a mediator of epithelial–mesenchymal transition and metastasis in colorectal cancer , 2013, The Journal of experimental medicine.

[104]  S. Reed,et al.  Ubiquitin ligases and cell cycle control. , 2013, Annual review of biochemistry.

[105]  G. Giaever,et al.  DNA-damaging agents in cancer chemotherapy: serendipity and chemical biology. , 2013, Chemistry & biology.

[106]  A. D'emanuele,et al.  Delivery of paclitaxel across cellular barriers using a dendrimer-based nanocarrier. , 2013, International journal of pharmaceutics.

[107]  A. Larsen,et al.  Irinotecan resistance is accompanied by upregulation of EGFR and Src signaling in human cancer models. , 2012, Current pharmaceutical design.

[108]  M. Aghi,et al.  Tumor cell autophagy as an adaptive response mediating resistance to treatments such as antiangiogenic therapy. , 2012, Cancer research.

[109]  John A. Todd,et al.  Proteome-Wide Analysis of Disease-Associated SNPs That Show Allele-Specific Transcription Factor Binding , 2012, PLoS genetics.

[110]  B. Li,et al.  Decreased Expression of SOX7 is Correlated with Poor Prognosis in Lung Adenocarcinoma Patients , 2012, Pathology & Oncology Research.

[111]  John D. Minna,et al.  miR-337-3p and Its Targets STAT3 and RAP1A Modulate Taxane Sensitivity in Non-Small Cell Lung Cancers , 2012, PloS one.

[112]  Yan Wang,et al.  P120-Catenin Isoforms 1 and 3 Regulate Proliferation and Cell Cycle of Lung Cancer Cells via β-Catenin and Kaiso Respectively , 2012, PloS one.

[113]  M. Ladanyi,et al.  Clarifying the Spectrum of Driver Oncogene Mutations in Biomarker-Verified Squamous Carcinoma of Lung: Lack of EGFR/KRAS and Presence of PIK3CA/AKT1 Mutations , 2012, Clinical Cancer Research.

[114]  Yi Jin,et al.  MicroRNA-138 suppresses epithelial-mesenchymal transition in squamous cell carcinoma cell lines. , 2011, The Biochemical journal.

[115]  Ivan Babic,et al.  Oncogenic EGFR signaling activates an mTORC2-NF-κB pathway that promotes chemotherapy resistance. , 2011, Cancer discovery.

[116]  I. Kim,et al.  microRNA-7 increases radiosensitivity of human cancer cells with activated EGFR-associated signaling. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[117]  Jun Du,et al.  Activation of Rac1-PI3K/Akt is required for epidermal growth factor-induced PAK1 activation and cell migration in MDA-MB-231 breast cancer cells , 2011, Journal of biomedical research.

[118]  A. Schmittel.  Second-line therapy for small-cell lung cancer , 2011, Expert review of anticancer therapy.

[119]  Hyung Gyun Kim,et al.  Metformin inhibits P‐glycoprotein expression via the NF‐κB pathway and CRE transcriptional activity through AMPK activation , 2011, British journal of pharmacology.

[120]  Masayuki Yamamoto,et al.  Molecular mechanisms of the Keap1–Nrf2 pathway in stress response and cancer evolution , 2011, Genes to cells : devoted to molecular & cellular mechanisms.

[121]  Hua-Chien Chen,et al.  EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF. , 2010, Cancer research.

[122]  Maria Kavallaris,et al.  Microtubules and resistance to tubulin-binding agents , 2010, Nature Reviews Cancer.

[123]  M. Jasin,et al.  Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesis , 2010, Nature Reviews Molecular Cell Biology.

[124]  B. Zhou,et al.  PTEN loss induces epithelial--mesenchymal transition in human colon cancer cells. , 2009, Anticancer research.

[125]  Hua Yu,et al.  STATs in cancer inflammation and immunity: a leading role for STAT3 , 2009, Nature Reviews Cancer.

[126]  Raghu Kalluri,et al.  The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.

[127]  H. Um,et al.  Signaling components involved in Bcl-w-induced migration of gastric cancer cells. , 2009, Cancer letters.

[128]  John S Mattick,et al.  Regulation of Epidermal Growth Factor Receptor Signaling in Human Cancer Cells by MicroRNA-7* , 2009, Journal of Biological Chemistry.

[129]  S. Kimura,et al.  Autophagy and autophagic cell death are next targets for elimination of the resistance to tyrosine kinase inhibitors , 2008, Cancer science.

[130]  Il-Jin Kim,et al.  FBXW7 Targets mTOR for Degradation and Cooperates with PTEN in Tumor Suppression , 2008, Science.

[131]  C. Moreno,et al.  Sox7 Is an Independent Checkpoint for β-Catenin Function in Prostate and Colon Epithelial Cells , 2008, Molecular Cancer Research.

[132]  B. Zhivotovsky,et al.  Death through a tragedy: mitotic catastrophe , 2008, Cell Death and Differentiation.

[133]  Yunqing Li,et al.  microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma. , 2008, Cancer research.

[134]  Daniel J. Klionsky,et al.  Autophagy fights disease through cellular self-digestion , 2008, Nature.

[135]  B. Clurman,et al.  FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation , 2008, Nature Reviews Cancer.

[136]  C. Caldas,et al.  The Extracellular Matrix Protein TGFBI Induces Microtubule Stabilization and Sensitizes Ovarian Cancers to Paclitaxel , 2007, Cancer cell.

[137]  M. Lainé,et al.  Cyclin-dependent kinase 2/cyclin E complex is involved in p120 catenin (p120ctn)-dependent cell growth control: a new role for p120ctn in cancer. , 2007, Cancer research.

[138]  Michael,et al.  Small cell lung cancer: have we made any progress over the last 25 years? , 2007, The oncologist.

[139]  D. Stewart,et al.  Mechanisms of resistance to cisplatin and carboplatin. , 2007, Critical reviews in oncology/hematology.

[140]  Héctor Peinado,et al.  Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? , 2007, Nature Reviews Cancer.

[141]  Anindya Dutta,et al.  UBE2T is the E2 in the Fanconi anemia pathway and undergoes negative autoregulation. , 2006, Molecular cell.

[142]  T. Ruzicka,et al.  Expression of cathepsin L and its inhibitor hurpin in inflammatory and neoplastic skin diseases , 2006, Experimental dermatology.

[143]  M. Dietel,et al.  Augmented expression of metallothionein and glutathione S-transferase pi as unfavourable prognostic factors in cisplatin-treated ovarian cancer patients , 2005, Virchows Archiv.

[144]  E. Manser,et al.  PAK and other Rho-associated kinases--effectors with surprisingly diverse mechanisms of regulation. , 2005, The Biochemical journal.

[145]  N. Mochizuki,et al.  Local Activation of Rap1 Contributes to Directional Vascular Endothelial Cell Migration Accompanied by Extension of Microtubules on Which RAPL, a Rap1-associating Molecule, Localizes* , 2005, Journal of Biological Chemistry.

[146]  C. Burge,et al.  Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.

[147]  Patricia L. Harris,et al.  Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. , 2004, The New England journal of medicine.

[148]  P. Seshiah,et al.  Phosphoinositide-Dependent Kinase 1 and p21-Activated Protein Kinase Mediate Reactive Oxygen Species–Dependent Regulation of Platelet-Derived Growth Factor–Induced Smooth Muscle Cell Migration , 2004, Circulation research.

[149]  J. D. Engel,et al.  Small Maf proteins serve as transcriptional cofactors for keratinocyte differentiation in the Keap1-Nrf2 regulatory pathway. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[150]  A. Rebbaa,et al.  Senescence-initiated Reversal of Drug Resistance , 2004, Cancer Research.

[151]  F. Fitzpatrick,et al.  Cyclooxygenase enzymes: regulation and function. , 2004, Current pharmaceutical design.

[152]  Albert B. Reynolds,et al.  A core function for p120-catenin in cadherin turnover , 2003, The Journal of cell biology.

[153]  Trevor Hastie,et al.  Gene expression patterns in ovarian carcinomas. , 2003, Molecular biology of the cell.

[154]  Mark Hannink,et al.  Distinct Cysteine Residues in Keap1 Are Required for Keap1-Dependent Ubiquitination of Nrf2 and for Stabilization of Nrf2 by Chemopreventive Agents and Oxidative Stress , 2003, Molecular and Cellular Biology.

[155]  M. Hansen,et al.  Ras GTPases: integrins' friends or foes? , 2003, Nature Reviews Molecular Cell Biology.

[156]  H. Young,et al.  Angiogenic effects of prostaglandin E2 are mediated by up-regulation of CXCR4 on human microvascular endothelial cells. , 2003, Blood.

[157]  J. Lis,et al.  PARP Goes Transcription , 2003, Cell.

[158]  F. van Roy,et al.  A novel role for p120 catenin in E-cadherin function , 2002, The Journal of cell biology.

[159]  M. Gullberg,et al.  MAP4 Counteracts Microtubule Catastrophe Promotion but Not Tubulin-Sequestering Activity in Intact Cells , 2002, Current Biology.

[160]  Li Mao,et al.  Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[161]  S. Narumiya,et al.  Acceleration of intestinal polyposis through prostaglandin receptor EP2 in ApcΔ716 knockout mice , 2001, Nature Medicine.

[162]  J. Norum,et al.  Molecular cloning of a mammalian nuclear phosphoprotein NUCKS, which serves as a substrate for Cdk1 in vivo. , 2001, European journal of biochemistry.

[163]  G. Baldacci,et al.  Rap1A protein interferes with various MAP kinase activating pathways in skeletal myogenic cells , 2000, Oncogene.

[164]  J. Wiśniewski,et al.  High mobility group I/Y: multifunctional chromosomal proteins causally involved in tumor progression and malignant transformation (review). , 2000, International journal of molecular medicine.

[165]  P Wadsworth,et al.  Taxol suppresses dynamics of individual microtubules in living human tumor cells. , 1999, Molecular biology of the cell.

[166]  D. Niethammer,et al.  Anthracycline-derived chemotherapeutics in apoptosis and free radical cytotoxicity (Review). , 1998, International journal of molecular medicine.

[167]  H. Yao,et al.  cAMP Activates MAP Kinase and Elk-1 through a B-Raf- and Rap1-Dependent Pathway , 1997, Cell.

[168]  V. Ferrans,et al.  Regulation of reactive-oxygen-species generation in fibroblasts by Rac1. , 1996, The Biochemical journal.

[169]  K. Gelmon.  The taxoids: paclitaxel and docetaxel , 1994, The Lancet.

[170]  L. Meijer,et al.  High-mobility-group proteins P1, I and Y as substrates of the M-phase-specific p34cdc2/cyclincdc13 kinase. , 1991, European journal of biochemistry.

[171]  S. Walaas,et al.  Phosphorylation of P1, a high mobility group‐like protein, catalyzed by casein kinase II, protein kinase C, cyclic AMP‐dependent protein kinase and calcium/calmodulin‐dependent protein kinase II , 1989, FEBS letters.

[172]  G. Maelandsmo,et al.  Phosphorylation of the high-mobility-group-like protein P1 by casein kinase-2. , 1989, European journal of biochemistry.

[173]  G. Kalemkerian,et al.  Small cell lung cancer , 2010, Seminars in Respiratory and Critical Care Medicine.

[174]  P. Schiff,et al.  Promotion of microtubule assembly in vitro by taxol , 1979, Nature.

[175]  Q. Peng,et al.  MiRNA-107 enhances chemosensitivity to paclitaxel by targeting antiapoptotic factor Bcl-w in non small cell lung cancer. , 2017, American journal of cancer research.

[176]  Zhu Jin,et al.  MicroRNA-138 regulates chemoresistance in human non-small cell lung cancer via epithelial mesenchymal transition. , 2016, European review for medical and pharmacological sciences.

[177]  Zhaochang Kang,et al.  Combination of Curcumin with an Anti-Transferrin Receptor Antibody Suppressed the Growth of Malignant Gliomas In vitro. , 2016, Turkish neurosurgery.

[178]  Da-Qiang Li,et al.  Unravelling the Complexity and Functions of MTA Coregulators in Human Cancer. , 2015, Advances in cancer research.

[179]  Varun Rastogi,et al.  Matrix metalloproteinases and cancer - roles in threat and therapy. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[180]  J. Baselga.  Targeting the phosphoinositide-3 (PI3) kinase pathway in breast cancer. , 2011, The oncologist.

[181]  D. Keppler,et al.  Multidrug resistance proteins (MRPs, ABCCs): importance for pathophysiology and drug therapy. , 2011, Handbook of experimental pharmacology.

[182]  S. Mousa,et al.  Cathepsin L inhibition suppresses drug resistance in vitro and in vivo: a putative mechanism. , 2009, American journal of physiology. Cell physiology.

[183]  Xianglin Shi,et al.  Reactive oxygen species regulate epidermal growth factor-induced vascular endothelial growth factor and hypoxia-inducible factor-1alpha expression through activation of AKT and P70S6K1 in human ovarian cancer cells. , 2006, Free radical biology & medicine.

[184]  A. Reynolds,et al.  Blocked acinar development, E-cadherin reduction, and intraepithelial neoplasia upon ablation of p120-catenin in the mouse salivary gland. , 2006, Developmental cell.

[185]  B R Goldspiel,et al.  Paclitaxel (Taxol) , 1994, Pharmacotherapy.

[186]  E. Nishida,et al.  Mitogen-activated-protein-kinase-catalyzed phosphorylation of microtubule-associated proteins, microtubule-associated protein 2 and microtubule-associated protein 4, induces an alteration in their function. , 1992, European journal of biochemistry.